Annals of the Rheumatic Diseases

{{more citations needed|date=June 2022}}

{{Infobox journal

| title = Annals of the Rheumatic Diseases

| cover =

| editor = Josef Smolen

| discipline = Rheumatology

| formernames =

| abbreviation = Ann. Rheum. Dis.

| publisher = Elsevier on behalf of the European Alliance of Associations for Rheumatology

| country =

| frequency = Monthly

| history = 1939–present

| openaccess = Hybrid

| license =

| impact = 20.3

| impact-year = 2023

| website = https://ard.eular.org/

| link1 = https://ard.eular.org/

| link1-name = Online access

| link2 = https://ard.eular.org/issues

| link2-name = Online archive

| ISSN =

| eISSN =

| OCLC =

| CODEN =

}}

The Annals of the Rheumatic Diseases is an international peer-reviewed medical journal. It is published by Elsevier on behalf of the European Alliance of Associations for Rheumatology and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. The journal publishes original research, reviews, recommendations, and various other articles, as well as abstracts from conferences.{{Cite web |title=Home Page: Annals of the Rheumatic Diseases |url=https://ard.eular.org/ |access-date=2025-03-20 |website=ard.eular.org}} The journal was established in 1939,{{Cite web |title=List of Issues: Annals of the Rheumatic Diseases |url=https://ard.eular.org/issues |access-date=2025-03-20 |website=ard.eular.org}} and operates under a hybrid subscription business model that enables open access.{{Cite web |title=Annals of the Rheumatic Diseases {{!}} Journal {{!}} ScienceDirect.com by Elsevier |url=https://www.sciencedirect.com/journal/annals-of-the-rheumatic-diseases |access-date=2025-03-20 |website=www.sciencedirect.com |language=en-us}} The editor-in-chief is Josef Smolen.{{Cite web |title=Editorial Board: Annals of the Rheumatic Diseases |url=https://ard.eular.org/content/edboard |access-date=2025-03-20 |website=ard.eular.org}}

Change of ownership and publisher

Until end of 2024, the Annals of the Rheumatic Diseases were published by BMJ.{{Cite web |title=Homepage |url=https://ard.bmj.com/ |access-date=2025-03-21 |website=Annals of the Rheumatic Diseases |language=en}} After a change of ownership, EULAR became the sole owner of the journal.{{Cite web |date=2025-03-21 |title=PDF.js viewer |url=https://www.eular.org/web/static/lib/pdfjs/web/viewer.html?file=https://www.eular.org/document/download/702/412c1a86-96e4-4089-86a6-c6554204c6f9/679 |url-status=live |archive-url= |access-date=2025-03-21 |website=www.eular.org}} Elsevier is the new publisher starting in January 2025.{{Cite web |date=2024-08-23 |title=PDF.js viewer |url=https://www.eular.org/web/static/lib/pdfjs/web/viewer.html?file=https://www.eular.org/document/download/928/1a199d2e-6bf5-4df0-9456-1536d7e7f8b0/855 |url-status=live |access-date=2025-03-21 |website=www.eular.org}}

Abstracting and indexing

The journal is abstracted and indexed in the Science Citation Index Expanded, Index Medicus, Excerpta Medica, and BIOSIS Previews. According to the Journal Citation Reports, its 2023 impact factor is 20.3.{{cite book |title=2023 Journal Citation Reports |title-link=Journal Citation Reports |publisher=Clarivate |year=2024 |edition=Science |series=Web of Science |chapter=Annals of the Rheumatic Diseases}}{{Cite web |title=Web of Science Master Journal List - WoS MJL by Clarivate |url=https://mjl.clarivate.com/search-results |access-date=2025-03-21 |website=mjl.clarivate.com}}

The journal has been cited most often by: Arthritis & Rheumatism, Annals of the Rheumatic Diseases, Rheumatology, Journal of Rheumatology, and Clinical and Experimental Rheumatology. The journals it has cited most are Arthritis & Rheumatism, Annals of the Rheumatic Diseases, Journal of Rheumatology, Rheumatology, and Journal of Immunology.

References